PhD Jih-Tung Pai MD

Learn More
Treatment for patients with intermediate-stage hepatocellular carcinoma (HCC) is controversial. This study compared the long-term survival of patients beyond the Milan criteria who received surgical resection (SR) or transarterial chemoembolization (TACE). A total of 268 and 455 HCC patients beyond the Milan criteria undergoing SR and TACE, respectively,(More)
  • 1